Last updated on February 2019

Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis

Brief description of study

The aim of this study is to investigate the efficacy of antibiotic therapy with any antibiotic (IV) and IV (Nebcin) tobramycin for 5 days followed by Solution for nebuliser inhalation (Tobi) for 9 days and antibiotic cures using 14 days of tobramycin IV. In the case of positive results, the reduction of the duration of IV treatment of tobramycin from 14 days to 5 days would limit the risk of toxicity.

Clinical Study Identifier: NCT03066453

Find a site near you

Start Over